Systech Radio

Counterfeit products are certainly top of mind for brands, governments and the media. However, they are only a part of the bigger gray market impacting the global supply chain. The lesser-known, but equally harmful scourge on supply chains is product diversion. In this episode, Steve Tallant sits down with Jim Sinisgalli, Senior Director of Systech's Solutions Consulting Group to discuss diversion, how the battle is being fought against it today and an approach Systech has that can help detect and solve diversion problems more rapidly.

Earlier this year the FDA called on the life sciences and healthcare industry to design pilot projects to create an interoperable pharmaceutical supply chain targeting DSCSA 2023 deadlines. Systech participated with multiple vendors, to create a solution vision that became an FDA finalist for the pilot. In this podcast, we join Joe Lipari to discuss how the joint proposal aims to tackle supply chain interoperability—exploring the pros and cons of blockchain for the pharma industry, the current status of the program and more.

On November 27, 2019, wholesale distributors in the pharma industry will be required to verify saleable returns using the now mandated serialized identifiers before they can redistribute them. Manufacturers will need to be able to respond to these verification requests within 24 hours, though the market expectation is for immediate response. In this podcast, industry expert Joe Lipari from Systech explains the upcoming mandate, its implications and some key action items pharma needs to take to ensure compliance by the November deadline.